<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iajabms</journal-id><journal-id journal-id-type="pubmed">IAJABMS</journal-id><journal-id journal-id-type="publisher">IAJABMS</journal-id><issn>2709-3298</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iajabms.2022.v03i01.006</article-id><title-group><article-title>Trends of Tuberculosis in a district of hilly state of North India: A Descriptive study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>Sumit</given-names><surname>Sharma</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Vikas</given-names><surname>Thakur</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Ankita</given-names><surname>Sharma</surname></name></contrib></contrib-group><aff-id id="aff-a" /><abstract>Introduction: Until the coronavirus (COVID-19) pandemic, TB was the leading cause of death from a single infectious agent, ranking above HIV/AIDS. TB is present in all countries and age groups. But TB is curable and preventable. Its persistent morbidity and mortality burden remains one of the major public health challenges in India. Globally, TB incidence is falling at about 2% per year and between 2015 and 2020 the cumulative reduction was 11%. This was over half way to the End TB Strategy milestone of 20% reduction between 2015 and 2020. United Nation Sustainable Development Goals (SDGs) and WHO’s End-TB strategy aims to end the global TB epidemic with targets to reduce TB deaths by 95% and to cut new cases by 90% by 2035 globally. India’s National Strategic plan 2017–2025 aims to achieve a TB free India, 5 years ahead of the global elimination plan. As it may take some time to achieve TB free status, in order to motivate States/Districts, interim recognition is also being given under the bronze, silver and gold categories based on improvement in TB score, increase in NNT and TB drug sale data. Methodology: This is an observational, descriptive study based on secondary data retrieved from Nikshay portal. The study population includes patients notified for tuberculosis from January 2017 through December 2021. The data was entered into Microsoft excel spreadsheet and was analyzed using Epi-info version 7. Due permissions were taken from higher authorities for data collection and publication. Results: A total of 3721 TB patients were notified between January 2017 to December 2021. A total of 3721 TB patients were notified during this period in the district. The mean age of study participants was 47±9.5 years. Majority (2577 i.e., 69%) of them were males. 298 (8%) were smokers, 59 (1.6%) were contacts of confirmed Tb case, 63 (1.7%) were migrant workers. Out of the total 95 patients were having drug resistant of any kind. 40 of them were put on Mono-H resistant regimen, 37 were on shorter MDR regimen, 8 on conventional MDR regimen, 7 on all longer oral regimen and 3 were on XDR regimen. Treatment success rate was 88%, NNT was 9 in 2017 and 14.2 in 2021. Annual TB incidence was 187 per lakh in 2017 and 165 in 2021. 70% patients were having Pulmonary TB, 1.3% were HIV positive, 11% were Diabetic and gap in notification for the district was almost 30% for each year. Conclusion and Recommendations: There is a need for rigorous efforts in diagnostic, treatment, ACSM activities to achieve the End TB strategy targets of TB elimination in the country till 2025.</abstract></article-meta></front><body /><back /></article>